Human parvovirus B19 infection mimicking systemic lupus erythematosus

Abstract Although several recent reports have discussed the similarities between human parvovirus B19 (HPV-B19) infection and systemic lupus erythematosus (SLE), the relationship between these conditions has not been established owing to the small number of patients investigated. In 1998–1999, an outbreak of Erythema infectiosum occurred close to our hospital, enabling us to investigate the clinical, hematological, and serological findings, including serum complement and antinuclear antibodies (ANA), in 22 patients with acute HPV-B19 infection. The principal symptoms included rash (86.3%), edema (59%), arthralgia (45.4%) and fever (31.8%). Lymphadenopathy was seen in three of the 22 cases. The laboratory findings showed high incidences of leukopenia (50%), hypocomplementemia (95%), and ANA (64.7%). At the time of disease onset, patients with acute HPV-B19 infection presented with features which were similar to those of SLE. The possibility of HPV-B19 infection should therefore be considered in patients presenting with SLE-like features.

[1]  T. Moore,et al.  Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. , 1999, Seminars in arthritis and rheumatism.

[2]  S. Trapani,et al.  Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. , 1999, Seminars in arthritis and rheumatism.

[3]  A. Sugawara,et al.  Human parvovirus B19 infection resembling systemic lupus erythematosus. , 1998, Internal medicine.

[4]  K. Sugamura,et al.  Human parvovirus B19 as a causative agent for rheumatoid arthritis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Naides.  Rheumatic manifestations of parvovirus B19 infection. , 1998, Rheumatic diseases clinics of North America.

[6]  E. Cosmi,et al.  Postpartum lupus erythematosus associated with parvovirus B19 infection. , 1997, The Journal of rheumatology.

[7]  F. Fawaz-Estrup.  Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus. , 1996, The Journal of rheumatology.

[8]  Bryan Paul Wordsworth,et al.  Effect of HLA type and hypocomplementaemia on the expression of parvovirus arthritis: one year follow up of an outbreak. , 1996, Annals of the rheumatic diseases.

[9]  A. Martínez-Rodríguez,et al.  Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  T. Moore,et al.  Parvovirus infection mimicking systemic lupus erythematosus. , 1995, Seminars in arthritis and rheumatism.

[11]  G. Boire,et al.  Chronic modulation of the autoimmune response following parvovirus B19 infection. , 1994, The Journal of rheumatology.

[12]  X. Le Loet,et al.  Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection. , 1993, British journal of rheumatology.

[13]  S. Glickstein.  Lupus-like presentation of human parvovirus B19 infection. , 1993, The Journal of rheumatology.

[14]  A. Cope,et al.  Possible induction of systemic lupus erythematosus by human parvovirus. , 1992, Annals of the rheumatic diseases.

[15]  M. Anderson,et al.  Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19. , 1989, The Journal of rheumatology.

[16]  K. Sugamura,et al.  An association between human parvovirus B-19 infection and autoantibody production. , 1989, The Journal of rheumatology.

[17]  A. Woolf,et al.  Clinical manifestations of human parvovirus B19 in adults. , 1989, Archives of internal medicine.

[18]  A. Woolf,et al.  HUMAN PARVOVIRUS ARTHROPATHY , 1985, The Lancet.

[19]  D. Reid,et al.  HUMAN PARVOVIRUS-ASSOCIATED ARTHRITIS: A CLINICAL AND LABORATORY DESCRIPTION , 1985, The Lancet.

[20]  F. Plummer,et al.  An erythema infectiosum-like illness caused by human parvovirus infection. , 1985, The New England journal of medicine.

[21]  J. Clewley,et al.  INTRAUTERINE PARVOVIRUS INFECTION ASSOCIATED WITH HYDROPS FETALIS , 1984, The Lancet.

[22]  M. Anderson,et al.  HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFTH DISEASE)? , 1983, The Lancet.

[23]  S. Jones,et al.  OUTBREAK OF APLASTIC CRISES IN SICKLE CELL ANAEMIA ASSOCIATED WITH PARVOVIRUS-LIKE AGENT , 1981, The Lancet.

[24]  H. J. Goldsmith,et al.  Letter: Re-use of disposable dialysers. , 1976, Lancet.

[25]  E. Caul,et al.  PARVOVIRUS-LIKE PARTICLES IN HUMAN SERA , 1975, The Lancet.

[26]  A. Midwinter,et al.  Letter: Transplacental lithium poisoning. , 1974, Lancet.